| 注册
首页|期刊导航|中国药房|甲钴胺联合前列地尔治疗糖尿病周围神经病变的疗效观察

甲钴胺联合前列地尔治疗糖尿病周围神经病变的疗效观察

寿砚芸

中国药房2011,Vol.22Issue(24):2285-2286,2.
中国药房2011,Vol.22Issue(24):2285-2286,2.

甲钴胺联合前列地尔治疗糖尿病周围神经病变的疗效观察

Efficacy Observation of Mecobalamin Alprostadil Treatment of Diabetic Peripheral Neuropathy

寿砚芸1

作者信息

  • 1. 浙江富阳市人民医院干部科,富阳市,311400
  • 折叠

摘要

Abstract

OBJECTIVE: To observe the methylcobalamin with alprostadil treatment of diabetic peripheral neuropathy. METHODS: The patients were given the 48 cases of diabetes diet, exercise, therapy and intensive insulin therapy, blood sugar stable, the observation group intramuscular injection of methylcobalamin 500 μg·d-1, qd, while intravenous infusion of alprostadil 100 μg·d-1, qd, continuous treatment of 30 d. The control group mecobalamin 500 μg·d 1, qd, treatment with the observation group. A course of treatment evaluated. RESULTS: The group' s effective rate was 97.92%, effective rate of the control group 79.17 % , a significant difference between the 2 groups (P<0.01). After treatment, the sensory nerve conduction velocity than before treatment (P<0.01), the difference was significant, and the observed changes in sensory nerve conduction velocity group than in the control group was significantly (P<0.01). CONCLUSION: Methylcobalamin with alprostadil treatment of diabetic peripheral neuropathy Diabetic peripheral neuropathy can improve symptoms, improve clinical efficacy.

关键词

甲钴胺/前列地尔/糖尿病周围神经病变

Key words

Methylcobalamin/ Alprostadil/ Diabetic peripheral neuropathy

分类

医药卫生

引用本文复制引用

寿砚芸..甲钴胺联合前列地尔治疗糖尿病周围神经病变的疗效观察[J].中国药房,2011,22(24):2285-2286,2.

中国药房

OACSCDCSTPCD

1001-0408

访问量4
|
下载量0
段落导航相关论文